Shari Lennon

650 citations
11 papers · 471 indexed · h-index 9
Topics
Platelet Disorders and Treatments (5 papers)Heparin-Induced Thrombocytopenia and Thrombosis (4 papers)Antibiotics Pharmacokinetics and Efficacy (3 papers)
Partner nations
United StatesFranceIndia

In The Last Decade

Shari Lennon

11 papers receiving 462 citations

Peers

Shari Lennon
Comparison fields: 5 of 57
  • Hematology 327
  • Public Health, Environmental and Occupational Health 101
  • Pharmacology 90
  • Pediatrics, Perinatology and Child Health 84
  • Molecular Biology 72
Replace F. Léger with:
F. Léger France
Geert van Waeg Sweden
Olga Bessmertny United States
L.S Leonardi Brazil
Monica Suet Ying Ng Australia
Rogier R. Press Netherlands
Christophe Gerbeau Switzerland
M Tasso Spain
Selina Moy United States
E. Giesbrecht Canada
Shari Lennon relative to F. Léger France F. Léger's profile →
Citations per field
00.5×1.5×2.2×
F. Léger · 1×
Citations per year

Countries citing papers authored by Shari Lennon

Since Specialization
Citations

This map shows the geographic impact of Shari Lennon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shari Lennon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shari Lennon more than expected).

Fields of papers citing papers by Shari Lennon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shari Lennon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shari Lennon. The network helps show where Shari Lennon may publish in the future.

Co-authorship network of co-authors of Shari Lennon

This figure shows the co-authorship network connecting the top 25 collaborators of Shari Lennon. A scholar is included among the top collaborators of Shari Lennon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shari Lennon. Shari Lennon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 74
2 86
3 111
4 11
5 4
6 52
7 34
8 80
9 8
10 8
11 3

About Shari Lennon

Shari Lennon is a scholar working on Hematology, Transplantation and Pharmacology, having authored 11 papers that have together received 471 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Hematology (327 citations), Transplantation (49 citations) and Biochemistry (65 citations). Shari Lennon has collaborated with scholars based in United States, France and India. Frequent co-authors include C. Puozzo, Laurent Nguyen, F. Léger, Douglas J. Christie, Hai T. Tran, Hugo F. Fernández, Robert B. Howe, Mark Goodman, Humberto Caldera and Ramzi Dagher. Their work appears in journals such as Blood, Clinical Pharmacology & Therapeutics and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026